219 related articles for article (PubMed ID: 24718613)
1. Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.
Treviño M; García-Riestra C; Areses P; García X; Navarro D; Suárez FJ; López-Dequidt IA; Zaragoza O; Cuenca-Estrella M
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1497-503. PubMed ID: 24718613
[TBL] [Abstract][Full Text] [Related]
2. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
3. [Trichosporon asahii].
Carnovale S; Guelfand L
Rev Argent Microbiol; 2012; 44(3):231. PubMed ID: 23102472
[No Abstract] [Full Text] [Related]
4. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.
Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G; Bosco-Borgeat ME
Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113
[TBL] [Abstract][Full Text] [Related]
5. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients.
Montoya AM; Sánchez González A; Palma-Nicolás JP; Gómez-Treviño A; González JG; González GM
Med Mycol; 2015 Jun; 53(5):505-11. PubMed ID: 25980003
[TBL] [Abstract][Full Text] [Related]
6. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
Dabas Y; Xess I; Kale P
Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
[TBL] [Abstract][Full Text] [Related]
7. Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis.
Padovan ACB; Rocha WPDS; Toti ACM; Freitas de Jesus DF; Chaves GM; Colombo AL
Fungal Genet Biol; 2019 Dec; 133():103267. PubMed ID: 31513917
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Rastogi V; Honnavar P; Rudramurthy SM; Pamidi U; Ghosh A; Chakrabarti A
Mycoses; 2016 Aug; 59(8):528-34. PubMed ID: 27144725
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Antifungal Susceptibility of Infections Caused by
Singh S; Capoor MR; Varshney S; Gupta DK; Verma PK; Ramesh V
Indian J Med Microbiol; 2019; 37(4):536-541. PubMed ID: 32436877
[TBL] [Abstract][Full Text] [Related]
10. A rare case of urinary tract infection due to Trichosporon asahii in a diabetic patient.
Iken M; Belkouch A; Bellarj B; Naoui H; Boumhil L; El Bouti A; Jidane S; Belyamani L; Lmimouni B
Pan Afr Med J; 2015; 20():127. PubMed ID: 26097631
[TBL] [Abstract][Full Text] [Related]
11. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of VITEK 2 for discriminating Trichosporon species: misidentification of Trichosporon non-T. asahii.
de Figueiredo DS; de Almeida JN; Motta AL; Castro e Silva DM; Szeszs MW; Del Negro GM
Diagn Microbiol Infect Dis; 2014 Sep; 80(1):59-61. PubMed ID: 24958642
[TBL] [Abstract][Full Text] [Related]
13. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China.
Guo LN; Xiao M; Kong F; Chen SC; Wang H; Sorrell TC; Jiang W; Dou HT; Li RY; Xu YC
J Clin Microbiol; 2011 Nov; 49(11):3805-11. PubMed ID: 21900517
[TBL] [Abstract][Full Text] [Related]
14. Invasive Infections Due to
Guo LN; Yu SY; Hsueh PR; Al-Hatmi AMS; Meis JF; Hagen F; Xiao M; Wang H; Barresi C; Zhou ML; de Hoog GS; Xu YC
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
[TBL] [Abstract][Full Text] [Related]
15. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
Xia Z; Yang R; Wang W; Cong L
Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
[TBL] [Abstract][Full Text] [Related]
16. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
[TBL] [Abstract][Full Text] [Related]
17. Prompt diagnosis and effective treatment of Trichosporon asahii catheter-related infection in non-immunocompromised neurosurgical patient.
Rubic Z; Novak A; Tomic Z; Goic-Barisic I; Radic M; Tonkic M
Mycopathologia; 2015 Feb; 179(1-2):125-8. PubMed ID: 25249355
[TBL] [Abstract][Full Text] [Related]
18. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil.
Menezes EA; Marinho JA; Angelo MR; Cunha Mda C; Cunha FA; Vasconcelos Júnior AA
Rev Inst Med Trop Sao Paulo; 2012; 54(1):1-3. PubMed ID: 22370746
[TBL] [Abstract][Full Text] [Related]
19. First genotype identification of Trichosporon asahii in Sfax, Tunisia.
Sellami H; Trabelsi H; Neji S; Amouri I; Cheikhrouhou F; Makni F; Ayadi A
J Med Microbiol; 2017 Apr; 66(4):397-401. PubMed ID: 28141498
[TBL] [Abstract][Full Text] [Related]
20. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
